About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 11605 record(s)
Req # A-2019-001593
Adverse Reaction Report (AER). Report number: E2B_02724537.Organization: Health Canada
January 2020
Req # A-2019-001600
Adverse Reaction Report (AER) for PANTOLOC. Report numbers: E2B_02734610, 729209.Organization: Health Canada
January 2020
Req # A-2019-001601
Adverse Reaction Report (AER) for PANTOPRAZOLE SODIUM. Report numbers: E2B_02720362, E2B_02743105, E2B_02743141, E2B_02743137, E2B_02753018, E2B_02757720, E2B_02758343, E2B_02764544.Organization: Health Canada
January 2020
Req # A-2019-001605
Adverse Reaction Report (AER) for ULORIC. Report numbers: E2B_02733828, E2B_02745370.Organization: Health Canada
January 2020
Req # A-2019-001607
Adverse Reaction Report (AER) for ALFUZOSIN HYDROCHLORIDE. Report number: E2B_01825720.Organization: Health Canada
January 2020
Req # A-2019-001644
Adverse Reaction Report (AER) for HYDROCHLOROTHIAZIDE, IRBESARTAN. Report number: 000718480.Organization: Health Canada
January 2020
Req # A-2019-001652
Adverse Reaction Report (AER) for NILUTAMIDE. Report number: E2B_02647482.Organization: Health Canada
January 2020
Req # A-2019-001679
Adverse Reaction Report (AER). Report number: E2B_02786752.Organization: Health Canada
January 2020
Req # A-2019-001629
Details of any current or pending proceedings, claims or remedies or any balance(s) owing to you by these Corporations. Federal business number, AH-SO FRANCHISE CORP., AH-SO FINE FOOD INC.Organization: Health Canada
January 2020
Req # A-2019-83837
Please provide copy of officer training manuals for purposes of training visa officer's in CPC-Ottawa and NHQ-CPR, on study permit applications. If training manuals are visa post specific, provide copies from the tem resident unit in Ankara visa post. If training manuals are visa country-specific, provide copies from the manuals/protocols used to process study permit applications for Iranian nationals. - Please provide copies of officer training manuals for purposes of training visa officer on use of software or artificial intelligence (AI) in processing initial study permit applications; specifically the negative or positive factors (points) given for country condition, travel history, previous refusal, conditional admission versus full admission, ELI versus main program, different provinces of Canada or other factors that the software is utilizing to make a decision for a certain application. - Please provide following statistics regarding initial study permits for Iranian nationals applications processed in Ankara visa post and CPC-Ottawa and NHQ-CPR in 2017, 2018 and 2019: Total applications received; approved, refused; level of education of primary-secondary, college, or university. - The procedure of processing reconsideration request for refused study permits and TRV applications in CPC-Ottawa and NHQ-CPR - Number of reconsideration requests for SP and TRV received in 2017, 2018, 2019 by CPC-O and NHQ-CPR; number of cases reopened and reconsidered.Organization: Immigration, Refugees and Citizenship Canada
January 2020